You are on page 1of 2

Elder Pharma To Launch About 32-35 New Products Over The Next 30 Months

* Of the various products underway, almost 8-9 self-researched products are in t


he pipeline in the womenâ s health care & nutraceutcials segment each which together
contribute almost 50% of the companyâ s turnover.
* The companyâ s R&D centre at Navi Mumbai has been expanded and modernized and now h
as about 100 scientists.
Mumbai, India, June 08, 2011 -- The Rs 800 crore Elder Pharmaceuticals Limited (
http://www.elderindia.com ), manufacturer of superbrand calcium supplement Shel
Cal, plans to launch almost 3 dozen new products in the coming 30 months in nich
e therapeutic segments like female healthcare, osteoporosis, Dermatology, pain m
anagement, Cardiology, nutraceuticals, wound care and vitamin supplements. This
will consist of a combination of in-licensed and own products although the large
r focus will be on self-researched products.
The company has a state-of-the-art Research & Development Centre at Navi Mumbai
which is recognized by the Department of Scientific & Industrial Research, Minis
try of Science & Technology. The R&D centre has recently been modernized and exp
anded and now consists of about 100 scientists.
Says Alok Saxena, Director, Elder Pharmaceuticals Ltd, ( http://www.elderindia.c
om ) "We are looking at launching atleast 8-9 products each in the Womenâ s healthcar
e & Nutraceuticals segments which are growing at an average of 18-20% annually -
higher than the 12-13% growth rate of the overall domestic pharma industry. Our
scientists are also working on new products, new drug delivery systems and comb
ination therapies in niche therapeutic segments like osteoporosis, dermatology,
cardiology, pain management, would care, vitamin supplements etc and we hope to
launch atleast 3-4 new products in each of these segments." The balance launches
will be in-licensed products. The company has earmarked an investment of about
Rs 120-130 crore for this.
The company is also looking at the wound care & pain management segments which c
urrently contribute about 16% to Elderâ s turnover and anticipated to grow at over 15
% every year. The mantra in these segments will be launch of therapies which are
non-invasive and having little or no side effects.
For Elder, major developments during FY 2011 were the hiking of stake in its ove
rseas acquisitions viz Neutra Health plc of UK [to 100%] and Elder Biomeda of Bu
lgaria [to 92%] and getting accreditation from Ministry of Japan for its state-o
f-the-art plant at Patalganga (Maharashtra). Following the accreditation, Elder
has developed two products going off patent in the Japanese market in 2014. One
of the products is from the CNS (Cerebro Neuropsychiarty Segment) category and t
he second is from the GI (Gastro Intestinal) segment. Elder has already filed a
PCT patent [an international patent application] for one of the advanced interme
diates for the Japanese market and is in talks with Japanese generic companies f
or supply contracts.
Elder Pharma is targeting a turnover of Rs 1500 cr by 2013.
About Elder Pharmaceuticals Limited:
Elder Pharmaceuticals Limited [NSE: ELDERPHARM] has presence in niche therapeuti
c segments like Womenâ s healthcare, Wound care, Nutraceuticals /vitamin Supplements,
Cardiology, Diabetes, Dermatology, Antibiotics and CNS. It is the market leader
in calcium supplements (Shelcal), wound healing and injectable B12 vitamin. The
company also has substantial interests in Medical Devices and non-pharmaceutica
l medical products. The company has a judicious mix of drug formulations, and ac
tive pharma ingredients (APIs). It has 7 manufacturing plants in India located i
n Maharashtra, Uttarakhand & Himachal Pradesh. ( http://www.elderindia.com )
Press & Media Contact:
Mitesh M Kapadia
Sentinel Public Relations Pvt Ltd / Sentinel Advertising Services
B-603, Samajdeep, Near Bhanu Park/Seasons Restaurant
Adukia Road, Off S V Road
Kandivli (W), Mumbai 400 067 India
Mob: +91 98205 03876
Tel: (022) 28625131/32
Fax: (022) 28625133
mitesh@publicrelationindia.com
http://www.publicrelationindia.com
http://www.elderindia.com

You might also like